Age-specific economic burden of respiratory syncytial virus (RSV) hospitalizations in the United States, 2009-2013: an analysis of healthcare cost and utilization project (HCUP) nationwide inpatient sample (NIS).
Systematic Literature Review to Assess Prevalence of Gina-defined Segments of Asthma and Phenotypes.
Combination Oncologics: A Boon or Burden to Healthcare Systems?
Special considerations and patient access schemes for oncology by health technology assessment (HTA) bodies: systematic evaluation in 25 countries.
Trends in research using observational methodologies in chronic lymphocytic leukemia (CLL): A systematic literature review.
Understanding Health Technology Assessment (HTA) bodies in major European markets: Systematic evaluation in 10 EU countries. Poster Presentation at the ISPOR 19th Annual European Congress, Vienna, Oct-Nov 2016.
Understanding Health Technology Assessment (HTA) bodies in major AsiaPacific (APAC) markets: Systematic evaluation in 10 APAC countries.
Understanding Health Technology Assessment (HTA) bodies in major Latin-American (LatAm) markets: Systematic evaluation in 5 LatAm countries.
Modeling the budget impact of availability of biosimilars of infliximab and adalimumab in rheumatoid arthritis using published claim-based algorithm data in the US.
Indirect Treatment Comparison of Newer Treatments in Relapsed/Refractory Multiple Myeloma: A study using OncoLitBank® Registry.
